Inflammatory Bowel Disease Treatment Market to be Worth $31.27 billion by 2030 - Latest Industry Insights by Business Market Insights

The Inflammatory Bowel Disease Treatment Market crossed US$ 21.30 billion in 2022 and is expected to hit US$ 31.27 billion by 2030, recording a CAGR of 4.9% during the forecast period

The report includes an executive summary, regional economic outlook, and summary sections which provide a consistent analysis of the Inflammatory Bowel Disease Treatment Market 2022 - 2030. in addition, the report within the market overview section outlines PLC analysis and PESTLE analysis to provide a thorough analysis of the market. The overview section details Porter's 5 forces analysis that helps to reveal a possible situation of the market by revealing a competitive situation with respect to the Inflammatory Bowel Disease Treatment Market.
Crohn's disease is a type of inflammatory bowel disease (IBD). It causes tissue swelling in the digestive tract, leading to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. According to the U.S. Department of Health and Human Services, researchers estimate that more than half a million people in the United States have Crohn's disease. Studies show that Crohn's disease has become more common in the United States and other parts of the world. Additionally, as of 2018, in Canada, the number of people with IBD is approximately 270,000 (0.7%). This number breaks down to 135,000 individuals living with Crohn's disease and 120,000 with ulcerative colitis.

Get a Sample Copy of Report, Click Here: https://www.businessmarketinsights.com/sample/BMIRE00026824?utm_source=OpenPr&utm_medium=10640

• Companies Profiled
o Pfizer Inc.
o Novartis AG
o Johnson & Johnson
o AbbVie Inc.
o Takeda Pharmaceutical Company Limited
o Allergan
o Celgene Corporation
o Bausch Health
o UCB, Inc.
o Cosmo Pharmaceuticals

The Inflammatory Bowel Disease Treatment market following are the manufacturers cover -
The leading players of the Inflammatory Bowel Disease Treatment industry, their market share, product portfolio, company profiles are covered during this report. Key market players are analyzed on the basis of production volume, gross margin, market value, and price structure. The competitive market scenario among Inflammatory Bowel Disease Treatment players will help the industry aspirants in planning their strategies. The statistics presented in this report are an accurate and helpful guide to shaping your business growth.

Market Segment by Type, the product can be divided into:
• Drug Class:
o Aminosalicyclates
o Immunomodulators
o TNF Inhibitors
o Corticosteroids

• Disease Indication:
o Crohn's Disease
o Ulcerative Colitis

• Distribution Channel:
o Hospital Pharmacy
o Online Pharmacy
o Retail Pharmacy

• Region:
o North America
o Europe
o Asia Pacific
o South & Central America
o Middle East & Africa

Recent strategic developments in the inflammatory bowel disease treatment market
The inflammatory bowel disease treatment market has undergone several significant developments, and a few of these have been mentioned below:
• In May 2021, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD). It is an oral medication used once daily for patients with moderately to severely active UC
• In July 2020, Takeda India, part of the Takeda Pharmaceutical Company, announced the expansion of its highly innovative portfolio for patients in the country with the launch of Kynteles (Vedolizumab) as part of its Gastrointestinal (GI) portfolio. Kynteles is used to treat adult patients with moderate to severely active ulcerative colitis (UC) and Crohn's Disease (CD)

Access Full Report@: https://www.businessmarketinsights.com/reports/inflammatory-bowel-disease-treatment-market

Market Segment by Application, split into:
This analysis report also presents practical and practical case studies to help you get a clearer understanding of the subject. This analysis report has been prepared through industry analysis techniques and presented in a professional manner by including effective information graphics whenever necessary. It helps ensure business stability and rapid development to achieve notable remarks within the Inflammatory Bowel Disease Treatment market.

Table of Contents: Inflammatory Bowel Disease Treatment Market 2022 - 2030
Chapter 1: Overview of Inflammatory Bowel Disease Treatment
Chapter 2: Regional Market Status and Forecast by Regions
Chapter 3: Regional Market Status and Forecast by Types
Chapter 4: Regional Market Status and Forecast by Downstream Industry
Chapter 5: Market driving correlational analysis
Chapter 6: Market competition status by major makers
Chapter 7: Major manufacturer's introduction and market data
Chapter 8: Upstream and downstream market analysis
Chapter 9: Cost and gross margin analysis
Chapter 10: Marketing status analysis
Chapter 11: Market report conclusion
Chapter 12: Research methodology and reference
Note: This report may be customized to suit your requirements. Get in touch with our sales team so you can get a report tailored to your needs.

Purchase a Copy of this Inflammatory Bowel Disease Treatment Market 2022 - 2030 research report at: https://www.businessmarketinsights.com/buy/single/BMIRE00026824?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any questions about this report or would like further information, please contact us:
Contact person: Sameer Joshi
Email: sales@businessmarketinsights.com
Phone: +16467917070

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.